All News #Library
Rare Diseases
Nxera Pharma Licenses Vamorolone For Duchenne Muscular Dystrophy
08 Jan 2026 //
GLOBENEWSWIRE
Nxera Pharma joins the World Orphan Drug Alliance
08 Apr 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support